Ames National Reports Strong Q4 & Full-Year 2025 Earnings, Raises 2026 EPS Guidance Significantly

summarizeSummary

Ames National Corporation announced strong Q4 and full-year 2025 earnings, with EPS nearly doubling, and provided significantly raised earnings guidance for 2026, driven by improved net interest income and efficiency.

check_boxKey Events

• Strong Q4 and Full-Year 2025 Earnings Growth

  Net income for Q4 2025 was $6.5 million ($0.73 per share), an 87% increase from $3.5 million ($0.39 per share) in Q4 2024. Full-year 2025 net income reached $19.0 million ($2.14 per share), an 88% increase from $10.2 million ($1.14 per share) in 2024.

• Significant 2026 EPS Guidance Increase

  The company is forecasting earnings for the year ending December 31, 2026, in the range of $2.70 to $2.80 per share, representing a substantial increase from the $2.14 per share earned in 2025.

• Improved Net Interest Margin and Efficiency

  Net interest margin improved to 3.00% in Q4 2025 from 2.38% in Q4 2024, driven by higher yields on loans and investments and a lower cost of funds. The efficiency ratio also significantly improved to 59.22% from 71.47% year-over-year.

• Increased Stockholders' Equity

  Total stockholders' equity increased to $207.9 million as of December 31, 2025, up from $174.7 million in 2024, primarily due to reduced unrealized losses on the investment portfolio and retained net income.

auto_awesomeAnalysis

Ames National Corporation delivered robust financial results for the fourth quarter and full year 2025, with net income and earnings per share nearly doubling year-over-year. This strong performance was primarily driven by a significant increase in net interest income, improved net interest margin, and enhanced operational efficiency. The company's forward-looking guidance for 2026, projecting a substantial increase in EPS to $2.70-$2.80 from $2.14 in 2025, signals a very positive outlook for future profitability. While there was a slight increase in substandard loans, the overall financial health and positive forecast are expected to reinforce investor confidence, especially as the stock trades near its 52-week high.